Table 1 Differentially expressed microRNAs in HCC versus adjacent non-tumor tissues from HBV-positive patients

miR-368

1.01E-12

3188

99

109

7

29.17

miR-487b

5.33E-15

2983

183

106

6

28.17

miR-127

6.02E-09

5319

145

218

20

24.36

miR-19b

1.33E-15

18,147

452

2382

83

7.62

miR-22

5.79E-08

3234

51

574

47

5.64

miR-181a

1.86E-09

5512

209

1519

105

3.63

miR-25

7.89E-10

8586

512

3491

201

2.46

miR-191

1.54E-10

8562

267

3521

155

2.43

miR-125b

1.86E-10

13,712

365

5849

270

2.34

miR-125a

1.04E-08

5357

389

2408

161

2.22

miR-27a

3.79E-11

12,665

409

5814

233

2.18

miR-24

1.03E-05

10,905

996

5138

161

2.12

miR-143

8.95E-10

8383

426

4040

186

2.08

miR-638

1.44E-10

22,023

780

10,794

454

2.04

miR-103

1.05E-09

7394

303

3661

199

2.02

miR-15a

6.98E-09

2089

79

4434

275

−2.13

miR-195

3.82E-10

7697

323

17,122

921

−2.22

miR-146a

1.36E-09

4030

253

10,074

647

−2.50

miR-361

3.78E-09

1933

156

6058

349

−3.13

miR-101

2.44E-09

964

97

3290

267

−3.45

miR-671

6.21E-11

1481

93

6074

245

−4.17

miR-152

5.71E-10

1118

42

4799

315

−4.35

miR-146b

1.13E-10

2357

230

11,701

826

−5.00

miR-451

3.67E-11

1985

90

10,252

700

−5.26

miR-98

2.16E-08

1009

180

5705

612

−5.56

miR-375

1.11E-08

623

61

4157

160

−6.67

miR-768-3p

4.00E-15

837

27

7214

281

−8.33

miR-10a

2.96E-11

351

41

4116

410

−11.11

miR-768-5p

2.36E-11

611

64

9400

606

−14.29

miR-335

1.57E-07

261

72

4499

692

−16.67

miR-29c

2.08E-10

416

67

7547

806

−16.67

miR-155

6.00E-12

310

19

5898

589

−20.00